Home/Hexagon Bio/Bill Grossman, MD, PhD

BG

Bill Grossman, MD, PhD

Chief Medical Officer

Therapeutic Areas

Hexagon Bio Pipeline

Drug	Indication	Phase
Undisclosed ADC Programs	Oncology (Resistant Cancers)	Pre-clinical

Leadership Team at Hexagon Bio

Maureen Hillenmeyer, PhD

Chief Executive Officer & Co-Founder

Tara Arvedson, PhD

Chief Scientific Officer

Kunal Patel, MBA

Senior Vice President, Business Development

View full Hexagon Bio profile